Most recent by Marco A. Zarbin, MD, PhD
SPONSORED CONTENT
November 08, 2023
5 min watch
Save
VIDEO: Analysis finds similar BCVA, superior CST for faricimab vs. aflibercept in DME
SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Marco A. Zarbin, MD, PhD, FACS, discusses a post hoc analysis of faricimab vs. aflibercept in patients with DME and visual acuity of 20/50 or worse.
SPONSORED CONTENT
September 05, 2021
1 min read
Save
PANORAMA trial results show efficacy of proactive anti-VEGF treatment for NPDR
New results suggest that proactive treatment of severe nonproliferative diabetic retinopathy with aflibercept injections may lead to improvement of disease severity.